Who invested in Generate Biomedicines

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Valuation: $1.0B, Oct 2024

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round: VentureDec 2024
Investors: 4

See who backed them

The rounds

Dec 2024
VentureAmount undisclosed
Source recorded

Founders and team

From Generate Biomedicines's own website: 1 founder, 16 on the team.

Gevorg GrigoryanCo-Founder & Chief Technology Officer

Jason SilversPresident & Chief Financial Officer
Michael NallyChief Executive Officer
Daria HazudaSenior Vice President, Discovery Strategy
Dinesh de AlwisSenior Vice President, Head of Clinical Drug Development
Sahm NasseriSenior Vice President, Business Development and Strategy
Aarif KhakooChief Scientific Officer
Beth GrousChief People Officer
Sean MartinChief Legal Officer & General Counsel
Frances ArnoldDirector
Jane MendilloDirector
Marsha FanucciDirector
Nancy SimonianDirector
Noubar AfeyanChair of the Board
Paul ParkerDirector
Rupert VesseyDirector
Stéphane BancelDirector

Everyone who backed them

Alumni VenturesVC firm1round

FidelityVC firm1round

ARCH Venture PartnersVC firm1round

nVenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Generate Biomedicines as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.